Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 165
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05245006 | PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer | ||
| NCT00058929 | A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension | ||
| NCT05203510 | A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension | ||
| NCT01027949 | An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension | ||
| NCT03055221 | TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) | ||
| NCT01494896 | Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching | ||
| NCT01884038 | Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients | ||
| NCT01980979 | Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension | ||
| NCT04708782 | Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT04411680 | Study of Sargramostim in Patients With COVID-19 | ||
| NCT01557660 | Inhaled Treprostinil for PAH: Open-label Extension | ||
| NCT03496623 | A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT06814717 | A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns | ||
| NCT04478071 | Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) | ||
| NCT03888365 | Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH | ||
| NCT00651885 | Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure | ||
| NCT01007890 | Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer | ||
| NCT02583789 | Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon | ||
| NCT02149095 | Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers | ||
| NCT01560637 | An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension | ||
| NCT03950739 | Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso | ||
| NCT05255991 | Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT06477640 | Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension | ||
| NCT00159250 | Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy | ||
| NCT06580444 | Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study | ||
| NCT05231122 | Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer | ||
| NCT04827056 | Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study | ||
| NCT06335407 | Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study | ||
| NCT00705133 | Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension | ||
| NCT00848107 | Open-Label Study of Oral Treprostinil in Digital Ulcers | ||
| NCT01104870 | A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension | ||
| NCT03857841 | A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD | ||
| NCT01477333 | Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® | ||
| NCT04084678 | Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects | ||
| NCT03814317 | Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension | ||
| NCT01042158 | A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis | ||
| NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | ||
| NCT01131845 | The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil | ||
| NCT02318758 | Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers | ||
| NCT00004497 | Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension | ||
| NCT00963027 | Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil | ||
| NCT01799473 | Tyvaso Dosing and Titration Evaluation: TyTRATE Registry | ||
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | ||
| NCT07612488 | A Study of CS231295 in Patients With Advanced Solid Tumors | ||
| NCT03481725 | Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study | ||
| NCT01353040 | Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus | ||
| NCT04870333 | PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V | ||
| NCT05776225 | Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection | ||
| NCT07261241 | NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab | ||
| NCT06425796 | Adiposity and Iron Requirements in Pregnancy |
